Inflammation as "common soil" of the multifactorial diseases

Autoimmunity Reviews

Volumn 10, Issue 7, 2011, Pages 369-374

  Scrivo, Rossana ^a   Vasile, Massimiliano ^a   Bartosiewicz, Izabella ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adipokines; Inflammation; MicroRNA; Psoriatic arthritis; Rheumatoid arthritis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INFLAMMASOME; LEPTIN; MICRORNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

AGING; ASTHMA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; DEGENERATIVE DISEASE; ENTERITIS; HOMEOSTASIS; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PSORIATIC ARTHRITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TARGET ORGAN; TISSUE INJURY;

HOMEOSTASIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 79955100645     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.12.006     Document Type: Review

References (40)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454(7203):428-435.
2. Witebsky E., Rose N.R., Terplan K., Paine J.R., Egan R.W. Chronic thyroiditis and autoimmunization. J Am Med Assoc 1957, 164(13):1439-1447.
3. Weyand C.M., Goronzy J.J. Pathogenesis of rheumatoid arthritis. Med Clin North Am 1997, 81(1):29-55.
4. Serdaroǧlu M., Cakirbay H., Deǧer O., Cengiz S., Kul S. The association of anti-CCP antibodies with disease activity in rheumatoid arthritis. Rheumatol Int 2008, 28(10):965-970.
5. Maas K., Chen H., Shyr Y., Olsen N.J., Aune T. Shared gene expression profiles in individuals with autoimmune disease and unaffected first degree relatives of individuals with autoimmune disease. Hum Mol Gen 2005, 14(10):1305-1314.
6. Carissimi C., Fulci V., Macino G. MicroRNAs: novel regulators of immunity. Autoimmun Rev 2009, 8(6):520-524.
7. Lago F., Dieguez C., Gómez-Reino J., Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007, 18(3-4):313-325.
8. Frommer K.W., Zimmermann B., Meier F.M., et al. Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis Rheum 2010, 62(10):2886-2899.
9. Bokarewa M., Bokarew D., Hultgren O., Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003, 62(10):952-956.
10. Spadaro A., Riccieri V., Scrivo R., Alessandri C., Valesini G. Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis. Clin Exp Rheumatol 2007, 25(4):599-604.
11. Chang J.C., Smith L.R., Froning K.J., et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sci. USA 1994, 91(20):9282-9286.
12. Hemdan N.Y., Birkenmeier G., Wichmann G., et al. Interleukin-17-producing T helper cells in autoimmunity. Autoimmun Rev 2010, 9(11):785-792.
13. Jandus C., Bioley G., Rivals J.P., Dudler J., Speiser D., Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008, 58(8):2307-2317.
14. Baeten D., Demetter P., Cuvelier C.A., et al. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol 2002, 196(3):343-350.
15. Rooney T., Murphy E., Benito M., et al. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann Rheum Dis 2004, 63(11):1393-1398.
16. Martin M.P., Nelson G., Lee J.H., et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002, 169(6):2818-2822.
17. Scrivo R., Morrone S., Spadaro A., Santoni A., Valesini G. Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level. Cytometry B Clin Cytom 2011, 80(1):22-27.
18. Kollnberger S., Chan A., Sun M.Y., et al. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol 2007, 37(5):1313-1322.
19. McGonagle D., Gibbon W., Emery P. Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352(9134):1137-1140.
20. McGonagle D., Lories R.J., Tan A.L., Benjamin M. The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 2007, 56(8):2482-2491.
21. Pattison E., Harrison B.J., Griffiths C.E., Silman A.J., Bruce I.N. Environmental risk factors for the development of psoriatic arthritis: results from a case control study. Ann Rheum Dis 2008, 67(5):672-676.
22. McDermott M.F., Aksentijevich I., Galon J., et al. Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999, 97(1):133-144.
23. Creagh E.M., O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006, 27(8):352-357.
24. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10(2):417-426.
25. Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440(7081):237-241.
26. Duewell P., Kono H., Rayner K.J., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464(7293):1357-1361.
27. Dostert C., Pétrilli V., van Bruggen R., Steele C., Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320(5876):674-677.
28. Shoenfeld Y, Agmon-Levin N. "ASIA"-Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2010 Aug 12 [Epub ahead of print].
29. Sitia S., Tomasoni L., Atzeni F., et al. From endothelial dysfunction to atherosclerosis. Autoimmun Rev 2010, 9(12):830-834.
30. Ouchi N., Kihara S., Arita Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001, 103(8):1057-1063.
31. Potenza M.V., Mechanick J.I. The metabolic syndrome: definition, global impact and pathophysiology. Nutr Clin Pract 2009, 24(5):560-577.
32. Maury E., Brichard S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010, 314(1):1-16.
33. Karastergiou K., Mohamed-Ali V. The autocrine and paracrine roles of adipokine. Mol Cell Endocrinol 2010, 318(1-2):69-78.
34. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA 2001, 286(3):327-334.
35. Karmiris K., Koutroubakis I.E., Kouroumalis E.A. Leptin, adiponectin, resistin and ghrelin: implications for inflammatory bowel disease. Mol Nutr Food Res 2008, 52(8):855-866.
36. May E., Märker-Hermann E., Wittig B.M., Zeitz M., Büschenfelde KH Meyer zum, Duchmann R. Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy. Gastroenterology 2000, 119(6):1745.
37. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454(7203):436-444.
38. Akiyama H., Barger S., Barnum S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21(3):383-421.
39. Whitton P.S. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 2007, 150(8):963-976.
40. Bruno A., Pace E., Chanez P., et al. Leptin and leptin receptor expression in asthma. J Allergy Clin Immunol 2009, 124(2):230-237.